TrialThe Lancet. Oncology2011

Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.

Anas Younes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.